Sichuan Kelun Pharmaceutical's (SHE:002422) attributable profit plunged 70% year over year to 200 million yuan in the third quarter, according to a Friday filing with the Shenzhen bourse.
The drug company logged earnings per share of 0.12 yuan, down 71% from the year-ago period.
Operating income declined 15% year on year to 4.19 billion yuan.
Shares closed 2% higher on Friday.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments